511
Participants
Start Date
May 23, 2017
Primary Completion Date
September 16, 2019
Study Completion Date
October 4, 2020
OBE2109
OBE2109 100mg tablets for oral administration once daily
Placebo to match OBE2109
Placebo to match OBE2109 100mg tablets for oral administration once daily
Placebo to match Add-back
Placebo to match Add-back (E2 1 mg / NETA 0.5 mg) for oral administration once daily
Add-back
Add-back (E2 1 mg / NETA 0.5 mg) for oral administration once daily
Site reference ID 933, West Seneca
Site reference ID 928, Erie
Site reference ID 931, Hamlet
Site reference ID 918, Huntington Park
Site reference ID 915, Augusta
Site reference ID 912, Orlando
Site reference ID 913, Bradenton
Site reference ID 919, West Columbia
Site reference ID 914, Westerville
Site reference ID 901, Canton
Site reference ID 932, Detroit
Site reference ID 917, Madison
Site reference ID 916, Jefferson City
Site reference ID 927, Metairie
Site reference ID 926, Covington
Site reference ID 907, Houston
Site reference ID 903, Denver
Site reference ID 924, Nampa
Site reference ID 911, Salt Lake City
Site reference ID 930, Albuquerque
Site reference ID 905, Chino
Site reference ID 902, San Diego
Site reference ID 900, Metairie
Site reference ID 265, Gabrovo
Site reference ID 255, Pleven
Site reference ID 258, Plovdiv
Site reference ID 266, Sliven
Site reference ID 264, Smolyan
Site reference ID 251, Sofia
Site reference ID 252, Sofia
Site reference ID 254, Sofia
Site reference ID 256, Sofia
Site reference ID 257, Sofia
Site reference ID 267, Sofia
Site reference ID 285, České Budějovice
Site reference ID 283, Písek
Site reference ID 281, Prague
Site reference ID 286, Prague
Site reference ID 287, Prague
Site reference ID 288, Prague
Site reference ID 284, Příbram
Site reference ID 289, Tábor
Site reference ID 282, Vsetín
Site reference ID 315, Baja
Site reference ID 303, Budapest
Site reference ID 307, Budapest
Site reference ID 301, Debrecen
Site reference ID 308, Debrecen
Site reference ID 313, Debrecen
Site reference ID 314, Kecskemét
Site reference ID 304, Kistarcsa
Site reference ID 306, Nyíregyháza
Site reference ID 451, Riga
Site reference ID 452, Riga
Site reference ID 454, Riga
Site reference ID 463, Kaunas
Site reference ID 460, Vilnius
Site reference ID 461, Vilnius
Site reference ID 464, Vilnius
Site reference ID 502, Bialystok
Site reference ID 504, Katowice
Site reference ID 509, Katowice
Site reference ID 513, Katowice
Site reference ID 514, Katowice
Site reference ID 501, Knurów
Site reference ID 510, Lodz
Site reference ID 517, Lodz
Site reference ID 506, Lublin
Site reference ID 508, Lublin
Site reference ID 511, Lublin
Site reference ID 519, Piaseczno
Site reference ID 518, Poznan
Site reference ID 505, Przemyśl
Site reference ID 503, Szczecin
Site reference ID 512, Świdnik
Site reference ID 507, Warsaw
Site reference ID 606, Brasov
Site reference ID 601, Bucharest
Site reference ID 603, Bucharest
Site reference ID 604, Bucharest
Site reference ID 605, Târgu Mureş
Site reference ID 813, Chernivtsi
Site reference ID 801, Ivano-Frankivsk
Site reference ID 814, Kharkiv
Site reference ID 802, Kyiv
Site reference ID 803, Kyiv
Site reference ID 805, Kyiv
Site reference ID 806, Kyiv
Site reference ID 807, Kyiv
Site reference ID 804, Lviv
Site reference ID 811, Odesa
Site reference ID 808, Ternopil
Site reference ID 817, Vinnytsia
Site reference ID 812, Zaporizhzhya
Site reference ID 815, Zaporizhzhya
Site reference ID 816, Zaporizhzhya
Lead Sponsor
ObsEva SA
INDUSTRY